Tuberculosis: all 1,435 studies

Page 11 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in AdultsCompletedNCT02074956Phase 1
• Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli AdultsCompletedNCT02073669Not applicable
• Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and ThailandCompletedNCT02073240
• A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis InfectionCompletedNCT02066428Phase 1
• Phase I Trial of DAR-901CompletedNCT02063555Phase 1
• TB-IRIS NSAID Cox-2 Inhibitor Prevention TrialStatus unknownNCT02060006Phase 3
• Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3CompletedNCT02057796Phase 4
• Evaluation of PTB Screening in ANC in Lusaka, ZambiaCompletedNCT02053129Not applicable
• Epidemiology and Diagnosis of Haemoptysis: a Multicenter StudyCompletedNCT02045394
• A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy VolunteersCompletedNCT02043314Phase 1
• Optimizing Clinical Outcomes in HIV-Infected Adults & ChildrenCompletedNCT02043080Not applicable
• Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIVCompletedNCT02043067
• The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot StudyCompletedNCT02042261
• Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS StudyCompletedNCT02027480
• Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium TuberculosisWithdrawnNCT02021747
• Linezolid Instead of Ethambutol in Treatment of Drug-susceptible TuberculosisStatus unknownNCT01994460Phase 2
• Vitamin D Supplementation and TBStatus unknownNCT01992263Not applicable
• The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in AfricaCompletedNCT01990274Not applicable
• Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infectionStatus unknownNCT01986543Phase 2
• Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent TuberculosisCompletedNCT01979900Phase 3
• TB Immunotherapy Trial With Heat-killed M. VaccaeCompletedNCT01977768Phase 3
• A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible BronchoscopyCompletedNCT01955824Phase 2/3
• Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector ImmunityCompletedNCT01954563Phase 1
• Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in ColombiaCompletedNCT01945905Not applicable
• Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western KenyaCompletedNCT01934309Not applicable
• A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking RifampinCompletedNCT01932268Phase 2
• Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult VolunteersCompletedNCT01927159Phase 1
• ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)CompletedNCT01926379Not applicable
• Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of PrednisoneCompletedNCT01924286Phase 3
• Performance of IGRAs for TB Infection Diagnosis in ElderlyTerminatedNCT01895582
• Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated AdultsCompletedNCT01879163Phase 1
• Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)Status unknownNCT01875952Phase 4
• Effects of SQ109 on QTc Interval in Healthy SubjectsWithdrawnNCT01874314Phase 1
• Start TB Patients on ART and Retain on Treatment (START Study)CompletedNCT01872390Not applicable
• Challenge Model for Assessment of Human TB ImmunityCompletedNCT01868464Phase 1
• Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence TomographyCompletedNCT01866579
• Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed InfantsCompletedNCT01861730Phase 1/2
• Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant TuberculosisCompletedNCT01856634Phase 1
• The Epidemiology of TST Change in KoreaCompletedNCT01850043
• The Impact of Involving Informal Health Providers for Tuberculosis Control in SudanCompletedNCT01841541Not applicable
• Bronchoscopic Sampling Techniques in SarcoidosisStatus unknownNCT01836822Not applicable
• Pharmacokinetic Parameters of Co-trimoxazoleCompletedNCT01832987Phase 2
• Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)CompletedNCT01830439Phase 1
• Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy AdultsCompletedNCT01829490Phase 1
• Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult SubjectsCompletedNCT01828827Phase 1
• Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in AdultsCompletedNCT01811823Phase 4
• Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous PreparationCompletedNCT01802502Phase 2
• The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis DrugsCompletedNCT01800487Not applicable
• Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)Status unknownNCT01798121Phase 2
• Equivalence Study of Specificity of PPDStatus unknownNCT01798095Phase 2
• Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesStatus unknownNCT01782950Phase 4
• Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration ResponsesCompletedNCT01779102Phase 2/3
• A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected PatientsCompletedNCT01770730Not applicable
• Evaluation of the Pharmacokinetic Interaction Between PA-824 and MidazolamCompletedNCT01768273Phase 1
• Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830Not applicable
• "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".TerminatedNCT01761201Phase 3
• Siemens VOC TB Pilot StudyCompletedNCT01748357
• PK/PD of Ertapenem In Patients With TBCompletedNCT01730664Phase 2
• Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
• Pharmacogenetics of Vitamin D Supplementation in TuberculosisCompletedNCT01722396Phase 3
• Preliminary Evaluation of a Point-Of-Care Liver Function TestCompletedNCT01705041Not applicable
• Rifampin and Efavirenz Interactions in Older ChildrenStatus unknownNCT01704144
• Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With RifampinTerminatedNCT01700790Phase 4
• Rifampin and Nevirapine Interactions in Young ChildrenStatus unknownNCT01699633
• Immune Reconstitution in Tuberculosis DiseaseCompletedNCT01698476Phase 2
• Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South AfricaStatus unknownNCT01693224Not applicable
• Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment OutcomesCompletedNCT01690754Not applicable
• Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV PatientsCompletedNCT01690403Phase 1
• Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)Status unknownNCT01689831Phase 2
• Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in GhanaStatus unknownNCT01687504
• The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis InfectionStatus unknownNCT01685905
• Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous PleurisyStatus unknownNCT01685099
• Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term DialysisStatus unknownNCT01685086
• Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85ACompletedNCT01683773Phase 1
• Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver DiseaseStatus unknownNCT01677871Not applicable
• The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary TuberculosisStatus unknownNCT01676155
• Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy VolunteersCompletedNCT01674218Phase 1
• Simplified Severe Sepsis Protocol-2 (SSSP-2) in ZambiaCompletedNCT01663701Not applicable
• EARNEST Rifabutin Pharmacokinetics (PK) SubstudyStatus unknownNCT01663168Phase 2
• Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The GambiaCompletedNCT01660646Not applicable
• Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in MongoliaCompletedNCT01657656Not applicable
• Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost VaccinationCompletedNCT01650389Phase 2
• A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSICompletedNCT01642888Phase 3
• Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary TuberculosisStatus unknownNCT01638520Phase 2
• Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)CompletedNCT01637558Phase 4
• Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSICompletedNCT01631266Phase 3
• Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to TuberculosisCompletedNCT01622140
• Reproducibility of Computed TomographyCompletedNCT01616264
• Positron Emission Tomography in Extrapulmonary TuberculosisCompletedNCT01613196Not applicable
• Gene Expression in HIV and Tuberculosis Co-infectionCompletedNCT01611402
• Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant RecipientsCompletedNCT01608685
• Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis InfectionCompletedNCT01601275
• A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium TuberculosisWithdrawnNCT01600963Phase 3
• Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedNCT01599897Phase 1
• Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRCCompletedNCT01589289Phase 3
• Evaluation of a LAM FLISA for the Diagnosis of TuberculosisCompletedNCT01587677
• Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis SuspectsCompletedNCT01587469
• Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy VolunteersCompletedNCT01585636Phase 1
• Alere Mycobacterium Tuberculosis Urine StudyCompletedNCT01585532
• Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)CompletedNCT01580007Phase 2

← Tuberculosis overview